AGN
ARGENICA FPO [AGN]
Healthcare · ASX Small Cap
$0.1800 -7.7%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when AGN triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is losing steam
- Above-average volume (1.9x) on a red day — sellers in control
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Drifting lower — down 10.0% over the last 5 days
- Adequate cash runway (6 quarters)
- 4C filed 2026-07-23
- Low P/S ratio (4.3x)
- Strong revenue growth (+1179%)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +1179% — the top line is moving in the right direction
- Altman Z-Score distress zone (1.77 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-25%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 35% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.33%/day)
Ask Scout AI about AGN
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Appendix 4G & Corporate Governance Statement
NONE Notification of cessation of securities - AGN
LOW Appendix 4E & Annual Report to 30 June 2026
LOW Investor Presentation - Techknow Conference
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-08-26 | Appendix 4G & Corporate Governance Statement |
| 2026-08-26 | Appendix 4E & Annual Report to 30 June 2026 PRICE SENSITIVE |
| 2026-08-13 | Notification of cessation of securities - AGN |
| 2026-07-26 | Investor Presentation - Techknow Conference |
| 2026-07-23 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$23.8M
Market Cap
74K
Avg Volume
1.9x
Vol Ratio
$0.09 — $0.38
52-Week Range
N/A
Short Interest
6 qtrs
Cash Runway
-20.8%
ROE
-24.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 76% |
| L | Leader vs Laggard | pass | RS: 19 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track AGN and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required